Über Roche
Nationalität
USA
Geburtsjahr
1968
1990
Biochemie, Harvard Medical School, A.B.
1999
Biochemie und Molekulare Pharmakologie, Harvard Medical School, Ph.D.
1999
Medizin, Harvard Medical School, M.D.
1999–2001
Massachusetts General Hospital, Internship and Residency in Innere Medizin
2001
Dana-Farber/Partners CancerCare, Fellowship in Medizinischer Onkologie
2003
Department of Medicine, Massachusetts General Hospital, Chief Resident
2004–2005
Laboratory of William Sellers, Dana-Farber Cancer Institute, Research Fellow
2005–2007
Dana-Farber Cancer Institute, Harvard Medical School, Instructor
2007–2011
Dana-Farber Cancer Institute, Harvard Medical School, Assistant Professor Medizin
2010–2016
Foundation Medicine, Mitgründer und Berater
2011–2016
Dana-Farber Cancer Institute, Harvard Medical School, Associate Professor Medizin
2017
Eli Lilly and Company, Senior Vice-President, Globale Onkologie
2017
Tango Therapeutics, Co-Founder
2018
Eli Lilly and Company, Senior Vice-President Oncology R&D and Novel Target Research
Seit 2019
Roche Basel, Executive Vice-President, Leiter der Globalen Produktentwicklung und Chief Medical Officer
–
–
2002–2007
Instructor, Harvard Medical School
2005–2016
Associate Physician Medizin, Brigham and Women’s Hospital
2006–2010
Associate Member, Krebsprogramm, Broad Institute of Massachusetts Institute of Technology (MIT) und Harvard
2006–2016
Mitglied, Biologische und Biomedizinische Wissenschaften Graduierten Programm, Abteilung für Biologische Chemie & Molekulare Pharmakologie, Harvard Medical School
2007–2011
Assistant Professor Medizin, Harvard Medical School
2010–2014
Senior Associate Member, Broad Institute
2011–2016
Assistant Professor Medizin, Harvard Medical School
2014–2016
Senior Associate Member, Broad Institute
2014–2016
Institute Member, Broad Institute
2016
Investigator, Howard Hughes Medical Institute
Seit 2020
Adjunct Professor, Department of Genetics, Stanford University School of Medicine
Seit 2021
Member, Board of Directors, Damon-Runyon Cancer Research Foundation
Seit 2023
Member, Board of Trustees, Dana-Farber Cancer Institute
Seit 2024
Member, Visiting Committee, Harvard Medical School and Harvard School of Dental Medicine
2007–2016
Consultant, Novartis Institutes for Biomedical Research
2008–2009
Consultant, Clinical & Translational Research Center, Harvard Medical School
2009–2011
Scientific Task Force, Lymphangioleiomyomatosis (LAM) Treatment Alliance
Seit 2011
Mitglied, Board of Scientific Consultants, Memorial Sloan-Kettering Cancer Center
2011–2016
Mitglied, External Scientific Advisory Board, The Ohio State University Comprehensive Cancer Center
Seit 2013
Mitglied, External Scientific Advisory Board, MD Anderson Cancer Center
2014–2016
Vorsitz, External Scientific Advisory Board, IGNITE Program, National Human Genome Research Institute (NHGRI)
Seit 2015
Mitglied, The V Foundation Scientific Advisory Board
2000–2003
National Medical Association
Seit 2007
American Association for Cancer Research
Seit 2009
American Society for Clinical Investigation
Seit 2010
American Association for the Advancement of Science
2011–2013
American Society for Biochemistry and Molecular Biology
Seit 2012
American Society for Clinical Oncology
Seit 2015
Association of American Physicians
Seit 2020
National Academy of Medicine
2003
Partners in Excellence Award
2007
NIH Director’s New Innovator Award
2009
American Society for Clinical Investigation (President, 2015)
2012
Block Award for Outstanding Cancer Research
2013
Paul Marks Prize for Cancer Research
2014
AACR-MICR Jane Cooke Wright Award
2014
Society for Melanoma Research Outstanding Investigator Award
2015
NCI Outstanding Investigator Award
2015
Association of American Physicians
2019
Academy of Fellows, American Association for Cancer Research
2019
Honorary doctorate, Feinstein Institute
2020
National Academy of Medicine
2022
Margaret J. Foti Award for Leadership and Extraordinary Achievement in Cancer Research
2022
Memorial Sloan-Kettering Medal and honorary doctorate, Gerstner/Sloan-Kettering Graduate School of Biomedical Sciences